Document:

Second Amendment to Amended and Restated Loan Agreement

 Exhibit 10.1 
 SECOND AMENDMENT TO 
 AMENDED AND RESTATED LOAN AGREEMENT

 THIS SECOND AMENDMENT TO AMENDED AND RESTATED LOAN AGREEMENT (the “Amendment”) is effective June 30,
2012, among GRAYMARK HEALTHCARE, INC., an Oklahoma corporation (“GRMH”), SDC HOLDINGS, LLC, an Oklahoma limited liability company (“SDC”) and APOTHECARYRx, LLC, an Oklahoma limited liability company (“ARx” together with
GRMH and SDC, jointly and severally the “Borrowers” and each a “Borrower”), OLIVER COMPANY HOLDINGS, LLC, an Oklahoma limited liability company (“OCH”), ROY T. OLIVER, an individual (“Oliver”), STANTON M.
NELSON, an individual (“Nelson”), ROY T. OLIVER, as Trustee of the Roy T. Oliver Revocable Trust dated June 15, 2004 (the “Trust” and together with OCH, Oliver and Nelson, the “Guarantors”) and ARVEST BANK, an
Arkansas banking corporation (the “Bank”). 
 W I T N E S S E T H 

WHEREAS, the Bank, the Borrowers and the Guarantors are all of the parties to the Amended and Restated Loan Agreement dated
December 17, 2010, as amended by the First Amendment to Amended and Restated Loan Agreement dated effective January 1, 2012 (the “Loan Agreement”); 
 WHEREAS the Borrowers and the Guarantors have requested that the Bank amend the Loan Agreement in connection with the proposed acquisition (the “Acquisition”) of the membership interests of
Foundation Surgery Affiliates, LLC and Foundation Surgical Hospital Affiliates, LLC; and 
 WHEREAS, the Bank has agreed to
amend the Loan Agreement on the terms and conditions set forth in this Amendment. 
 NOW THEREFORE, for good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows: 
 1. Definitions. Except as
otherwise defined in this Amendment, capitalized terms used in this Amendment will have the same definition in this Amendment as those terms are defined in the Loan Agreement. 
 2. Amending Paragraph 9.10. Paragraph 9.10 of the Loan Agreement is hereby deleted in its entirety and the following is inserted in its place: 

 

	 	9.10	Operation. The Borrowers agree to operate the sleep lab, surgical center and hospital businesses directly, or indirectly, through the Borrower Subsidiaries in a
prudent and efficient manner consistent with normal industry practices and all governing laws and regulations. 

 3. Amending
Paragraph 9.11. Paragraph 9.11 of the Loan Agreement is hereby deleted in its entirety and the following is inserted in its place: 

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
  

	 	9.11	Qualifications; Licenses. Borrowers will take such actions or cause such actions to be taken as might be required to maintain the existence of all governmental
and private permits, licenses and authorities of the Borrowers and Borrower Subsidiaries, necessary or desirable to the continuation of the sleep lab, surgical center and hospital businesses and will comply with all statutes and governmental
regulations. 

 4. Amending Paragraph 9.13. Paragraph 9.13 of the Loan Agreement is hereby deleted in its entirety and the
following is inserted in its place: 
  

	 	9.13	Attorney Fees. The Borrowers must pay or cause to be paid to the Bank in immediately available funds all legal fees and expenses incurred by the Bank in
connection with the Acquisition, the Borrowers’ requests for accommodation and any amendments to the Loan Agreement and any related documents within ten days after being presented with a request for reimbursement by Arvest.

 5. Amending Paragraph 9.14. Paragraph 9.14 of the Loan Agreement is hereby deleted in its entirety and the following is
inserted in its place: 
  

	 	9.14.	Required Prepayments. On or before June 30, 2012, the Borrowers must: (a) pay or cause to be paid to the Bank in immediately available funds an amount
not less than $351,000.00. On or before August 31, 2012, the Borrowers must (a) pay or cause to be paid to the Bank by check the aggregate of all payments of principal and interest that would otherwise become due under the Loan Documents
between June 30, 2012, and December 31, 2012, less $351,000.00, with the principal to be immediately applied to the indebtedness of the Borrowers owed to the Bank in accordance with the Loan Documents; and the interest to be deposited in a
special account maintained with the Bank (the “Required Prepayment Account”) to be applied by the Bank on the dates such interest payments become due, except that after Default the Bank may immediately apply such funds to the
Borrowers’ indebtedness to the Bank in the Bank’s sole and absolute discretion. The Required Prepayment Account will be a restricted account and except for the deposits required under the Loan Documents, the Borrower will not be entitled
to make any deposit to or withdrawal from the Required Prepayment Account. The Borrower hereby grants the Bank a security interest in the Required Prepayment Account and agrees to execute and deliver a security agreement in form and substance
satisfactory to the Bank evidencing such security interest. 

 6. Amending Paragraph 9.15. Paragraph 9.15 of the Loan
Agreement is hereby deleted in its entirety and the following is inserted in its place: 
  

	 	9.15.	Positive EBITDA. Beginning on March 31, 2013, and on the last day of each quarter thereafter, the Borrower’s EBITDA must be positive for such
immediately ended quarter. “EBITDA” for any period means the net income for that period: (a) plus the following for such period to the extent deducted in calculating such net income, without duplication: (i) interest expense,
(ii) all income tax expense; (iii) depreciation and amortization expense; and (iv) non-cash charges constituting intangible impairment charges, equity compensation and fixed asset impairment charges; (b) but, and in all cases,
excluding from the calculation of EBITDA: (i) any extraordinary items (as determined in accordance with GAAP); and (ii) one-time or non-recurring gains or losses associated with the sale or disposition of any business, asset, contract or
lease. 

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
 - 2 - 

 7. Amending Paragraph 10.4. The following sentence is hereby appended to the end of paragraph 10.4 of
the Loan Agreement: 
 For the purposes of this paragraph 10.4, neither Foundation Surgery Affiliates, LLC and Foundation
Surgical Hospital Affiliates, LLC, nor any of their respective subsidiaries (collectively, “Foundation”) will be Borrower Subsidiaries. 
 8. Amending Paragraph 10.8. Clause (c) of paragraph 10.8 of the Loan Agreement is hereby deleted in its entirety and the following is inserted in its place: 

(c) make any acquisitions of or capital contributions to or other investments in any person or entity, in each case, other than the
planned and disclosed expansion of the sleep lab, surgery center and hospital businesses in which the Borrowers or Foundation are currently engaged. 
 9. Amendment to Paragraph 10.11. Paragraph 10.11 of the Loan Agreement is hereby deleted and the following inserted in its place: 

 

	 	10.11.	Debt Service Coverage Ratio. Commencing with the Quarter beginning April 1, 2013, and thereafter during the term of the Loan, based on the latest four
rolling quarters, the Borrowers will continuously maintain a Debt Service Coverage Ratio of not less than 1.25 to 1. 

 10.
Amendment to Paragraph 10.12. Paragraph 10.12 of the Loan Agreement is hereby deleted and the following inserted in its place: 
  

	 	10.12	Minimum Net Worth. Beginning on March 31, 2013, Borrowers will continuously maintain the Minimum Net Worth determined on a quarterly basis.

 11. Amendment to Paragraph 11.12. Paragraph 11.12 of the Loan Agreement is hereby deleted and the following inserted in
its place: 
  

	 	11.12.	Stock Suspension. On or after January 1, 2013, trading of the stock of GRMH has been suspended for more than thirty days or delisted from the OTCBB, OTCQB
or other similar over-the-counter market on which the stock is hereafter quoted and traded. 

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
 - 3 - 

 12. Consent to the Acquisition. Subject to the conditions set forth in paragraph 21, the Bank:
(a) consents to the consummation of the Acquisition by GRMH or a newly formed Borrower Subsidiary owned 100% by GRMH; (b) waives the application of and agrees that paragraphs 10.1, 10.2, 10.3 and 10.10 of the Loan Agreement will not apply
to Foundation; (c) waives the application of and agrees that the first, third and fourth sentences of paragraph 10.5 of the Loan Agreement will not apply with respect to Foundation and its subsidiaries; and (d) waives the application of
and agrees that paragraph 10.8 of the Loan Agreement will not apply to the Foundation assets and the equity interests of Foundation Surgery Affiliates, LLC, and Foundation Surgical Hospital Affiliates, LLC. For purposes of the Borrower financial
reporting covenants (Minimum Net Worth, Debt Service Coverage Ratio and positive EBITDA) under the Loan Agreement as amended, Foundation will be included in accordance with GAAP. 
 13. Foundation Advances. Notwithstanding any other provision of the Loan Documents, Foundation is permitted to make inter-company loans or advances to GRMH for the purpose of paying GRMH’s
operating expenses and satisfying the Borrowers’ obligations to the Bank, except that no such loan may provide for any payments while any of the Borrowers’ obligations to the Bank remain outstanding. 

14. Foundation Contributions. Except for funds acquired in an equity offering by GRMH for the purpose of funding a surgical center or hospital
acquisition by Foundation, no Borrower may contribute, advance or otherwise disburse funds to Foundation. 
 15. Foundation Collateral.
While Foundation is still indebted to Legacy Bank, or any successor lender in the case of a refinancing of the Legacy debt, the membership interests in and assets of Foundation Surgery Affiliates, LLC, and Foundation Surgical Hospital Affiliates,
LLC, and their respective subsidiaries will not be Collateral under the Loan Documents and will not be required to be pledged to Arvest under the Loan Documents. 
 16. Minimum Liquidity; Minimum Net Worth. Any failure by the Borrowers under the Loan Agreement to meet the Minimum Liquidity requirement of (former) paragraph 9.13 and the Minimum Net Worth
requirement of (former) paragraph 10.12 of the Loan Agreement is hereby waived. 
 17. Consent to Distribution. If (i) no uncured
Default exists and is continuing; and (ii) on or before April 1, 2013, the Borrowers (a) pay or cause to be paid to the Bank in immediately available funds the aggregate of all payments of principal that would otherwise become due
under the Loan Documents between April 1, 2013, and October 1, 2013, to be immediately applied to the indebtedness of the Borrowers owed to the Bank in accordance with the Loan Documents; and (b) deposit or cause to be deposited in
the Required Prepayment Account the aggregate of all interest payments that would otherwise become due under the Loan Documents between April 1, 2013, and October 1, 2013 (to be applied by the Bank to on the dates such interest payments
become due, except that after Default the Bank may immediately apply such funds to the Borrowers’ indebtedness to the Bank in the Bank’s sole and absolute discretion), then Graymark may pay or cause one or more of its subsidiaries to
distribute to the existing Foundation preferred holders $2,600,000.00 pursuant to the existing Operating Agreements for Foundation. Except as permitted by this paragraph 17, no distribution may be made to any equity holder of Foundation Surgery
Affiliates, LLC, or Foundation Surgical Hospital Affiliates, LLC (other than a Borrower), while the Borrower’s obligations to the Bank remain outstanding. 

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
 - 4 - 

 18. Waiver of Foundation Loan Covenants. The Borrowers will cause Foundation’s existing lender
Legacy Bank, or the successor lender to Foundation in the case of a refinancing of the Legacy debt, Foundation, the Borrowers and the Guarantors, the Bank and all existing equity holders of Foundation who will receive GRMH stock in connection with
the Acquisition to enter into an agreement on or before December 31, 2012, in form and substance satisfactory to the Bank, providing that Foundation may distribute or advance money from Foundation to the Borrowers to service the Borrowers’
obligations to Arvest and to pay the Borrowers’ operating expenses. 
 19. Balances; Further Advances. As of July 1, 2012,
after applying the $351,709.60 partial payment made on June 30, 2012, the principal balance under the: (a) Term Note is $4,403,621.23, with accrued interest of $22,018.11 accruing at the per diem rate of $733.6368; and (b) Acquisition
Note is $13,338,829.23, with accrued interest of $30,123.62 accruing at the per diem of $2,223.1382. Notwithstanding any other provision of this Agreement, the Bank has no further obligation to make any advances under either of the Notes.

 20. Release. On execution of this Agreement, each of the Borrowers and the Guarantors hereby unconditionally and irrevocably release,
acquit, waive and forever discharge the Bank and its participants, subsidiaries, affiliates, directors, officers, shareholders, employees, agents, attorneys, representatives and each of their respective heirs, legal representatives, executors,
administrators, successors and assigns (the “Released Parties”) from any and all duties, obligations, representations, claims, actions, suits, causes of action, demands, liabilities, losses, damages, contracts, agreements, obligations,
accounts, defenses and offsets of any kind or character whatsoever, known or unknown, suspected or unsuspected, in contract or in tort, at law or in equity, asserted or assertable, now existing or hereafter to accrue which the Borrowers or
Guarantors ever had, now have or may hereafter have against the Released Parties, jointly or severally, for or by any reason or matter, cause or thing whatsoever occurring prior to the date of this Agreement, including without limitation such claims
and defenses as fraud, mistake, duress and usury which relate, in whole or in part, directly or indirectly, to (a) the Loan Documents, the loan transactions evidenced thereby or any agreements or commitments in connection therewith; and
(b) any past or present account relationship of the Borrowers, the Guarantors or any of their affiliates with the Bank. In addition, the Borrowers and Guarantors each agree not to sue any of the Released Parties regarding any of the foregoing
matters. 
 21. Conditions to Effectiveness. This Amendment will not be effective until executed and delivered by all parties and the
Borrowers have paid or caused to be paid to the Bank a non-refundable fee in the amount of $22,474.49 in immediately available funds and the Borrowers will have paid or caused to be paid $1,184,808.03 to the bank by check to be applied pursuant to
paragraph 9.14 of the Loan Agreement when the Bank receives collected funds. 
 22. Supersession. Except as specifically amended by this
Amendment, the Loan Agreement and the other Loan Documents remain in full force and effect. 
 [Signature Pages Follow]

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
 - 5 - 

 SIGNATURE PAGE TO SECOND AMENDMENT TO 

AMENDED AND RESTATED LOAN AGREEMENT 
 IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first above written. 
  

			
	BANK:
	
	ARVEST BANK, an Arkansas banking corporation
		
	By:	 	/s/ Bradley W. Krieger
		 	Bradley W. Krieger, Executive Vice President and Regional Manager

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 

 SIGNATURE PAGE TO SECOND AMENDMENT TO 

AMENDED AND RESTATED LOAN AGREEMENT 
 IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first above written. 
  

					
	BORROWER:
	
	GRAYMARK HEALTHCARE, INC., an Oklahoma corporation
		
	By:	 	/s/ Stanton M. Nelson
		 	Stanton M. Nelson, CEO
	
	BORROWER:
	
	APOTHECARYRX LLC, an Oklahoma limited liability company
		
	By:	 	Graymark Healthcare, Inc., an Oklahoma corporation, its Manager
			
		 	By:	 	/s/ Stanton M. Nelson
		 		 	Stanton M. Nelson, CEO
	
	BORROWER:
	
	SDC HOLDINGS, LLC, an Oklahoma limited liability company
		
	By:	 	Graymark Healthcare, Inc., an Oklahoma corporation, its Manager
			
		 	By:	 	/s/ Stanton M. Nelson
		 		 	Stanton M. Nelson, CEO
	
	GUARANTOR:
	
	/s/ Stanton M. Nelson
	STANTON M. NELSON, individually

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENT 
  

 SIGNATURE PAGE TO SECOND AMENDMENT TO 

AMENDED AND RESTATED LOAN AGREEMENT 
 IN WITNESS WHEREOF, the parties have executed this Agreement effective the date first above written. 
  

			
	GUARANTOR:
	
	OLIVER COMPANY HOLDINGS, LLC, an Oklahoma limited liability company
		
	By:	 	/s/ Roy T. Oliver
		 	Roy T. Oliver, Manager

  

	
	GUARANTOR:
	
	/s/ Roy T. Oliver
	ROY T. OLIVER, individually

  

	
	GUARANTOR:
	
	/s/ Roy T. Oliver
	 ROY T. OLIVER, Trustee of the Roy T. Oliver
 Revocable Trust, u/t/a dated June 15, 2004

  
 SECOND
AMENDMENT TO 
 AMENDED AND RESTATED LOAN
AGREEMENTPromissory Note

 Exhibit 10.2 
 PROMISSORY NOTE 
  

			
	$1,184,808.03	 	 August 31, 2012
 Oklahoma City Oklahoma

 FOR VALUE RECEIVED, the undersigned, Graymark Healthcare, Inc., an Oklahoma Corporation (the
“Borrower”), promises to pay to the order of Roy T. Oliver (the payee, its successors and assigns are hereinafter called the “Lender”), at 101 N. Robinson, Ste. 900, Oklahoma City, Oklahoma 73102, or at such other place as may be
designated in writing by the Lender, on March 31, 2013 (the “Maturity Date”) the principal sum of One Million, One Hundred Eighty-Four Thousand, Eight Hundred Eight Dollars and 03/100cents ($1,184,808.03) in lawful money of the
United States, together with interest accruing from the date hereof at the rates hereinafter specified, payable as follows: 

Prior to Default, the unpaid principal balance of this Note will bear interest from the date hereof at the rate of eight percent
(8%) per annum. Interest will be computed on a per diem charge based on a three hundred sixty (360) day year. The entire unpaid principal balance of this Note plus all accrued and unpaid interest thereon will be due and payable on
March 31, 2013 (the “Maturity Date”). All payments made under this Note shall be applied first to any accrued interest, fees and costs, and then to principal. Payments hereunder may, at the option of the Lender, be recorded on this
Note or on the books and records of the Lender and will be prima facie evidence of said payments and the unpaid balance of this Note. No payment will be applied to this Note until received by the Lender in collected funds. The holder without the
prior consent of Maker may assign this Note and any security therefor.
 Maker may not re-borrow under this Note and this Note
is not on a revolver basis. This Note has been fully advanced. The Maker shall have the right to prepay this Note in whole or in part at any time and from time to time without premium or penalty, but with interest to the date of payment on the
amount prepaid. 
 In the event Maker defaults in the terms of this Note, fails to pay this Note (principal or interest) when
due, or in the event Maker shall enter into an assignment for the benefit of creditors or admit its inability to pay debts as they become due, or in the event of the commencement of any bankruptcy or like proceeding against or by Maker, or in the
event of a default by Maker under the terms of those certain loan documents as evidenced by the Amended and Restated Loan Agreement by and between Maker (and others) and Arvest Bank, dated effective December 17, 2010, and all amendments,
waivers and consents pertaining thereto (the “Arvest Loan Documents”) that is not timely cured (in any such case a “Default”), thereupon, and in any such event and at any time thereafter during the continuance of such event, this
Note shall, at the election of Lender, become due and payable in full, without presentment, demand, protest or any further notice of any kind, anything contained herein to the contrary notwithstanding. In the event of a Default, thereafter the
principal balance of this Note then due and owing shall bear interest at the rate of Fifteen Percent (15%) per annum (the “Default Rate”). 

 In the event of Default, the Lender will have available all remedies at law or equity,
including all rights and remedies under the Uniform Commercial Code. The Lender will be entitled to proceed to selectively and successively enforce the Lender’s rights without waiver or discharge. The Maker agrees that if, and as often as, this
Note is placed in the hands of an attorney for collection or to defend or enforce any of the holder’s rights hereunder, the Maker shall pay to the holder hereof his reasonable attorney’s fees, together with all court costs and other
expenses incurred and paid by such holder.
 The Maker, endorser, surety, guarantor and all other persons who may become liable
for all or any part of this obligation severally waive presentment for payment, protest and notice of nonpayment. Said parties consent to any extension of time (whether one or more) of payment hereof, any renewal (whether one or more) hereof,
and any release of any party liable for payment of this obligation. Any such extension, renewal or release may be made without notice to such party and without discharging said party’s liability hereunder.

The failure of the holder hereof to exercise any of the remedies or options set forth in this Note or in any instrument securing payment
hereof, upon the occurrence of one or more events of default, shall not constitute a waiver of the right to exercise the same or any other remedy at any subsequent time in respect to the same or any other event of default. The acceptance of the
holder hereof of any payment which is less than the total of all amounts due and payable at the time of such payment shall not constitute a waiver of the right to exercise any of the foregoing remedies or options at that time or any subsequent time,
or nullify any prior exercise of any such remedy or option, without the express consent of the holder hereof, except as and to the extent otherwise provided by law.
 MAKER AND LENDER DO HEREBY IRREVOCABLY, KNOWINGLY, VOLUNTARILY AND INTENTIONALLY WAIVE THEIR RIGHT TO A TRIAL BY JURY IN RESPECT OF ANY LITIGATION BASED HEREON, OR ARISING OUT OF, OR UNDER OR IN
CONNECTION WITH THIS NOTE OR ANY DOCUMENT DELIVERED IN CONNECTION HEREWITH. This Note is made under and is to be governed and construed by the internal laws of the State of Oklahoma. All actions with respect to this Note shall be instituted
solely and exclusively in the courts of the State of Oklahoma sitting in Oklahoma County, Oklahoma, or the United States District Court for the Western District of Oklahoma, sitting in Oklahoma City, Oklahoma, as the Lender may elect, and by
execution and delivery of this Note, the Maker irrevocably and unconditionally submits to the exclusive jurisdiction (both subject matter and personal) of each such court and irrevocably and unconditionally waives: (a) any objection the Maker
might now or hereafter have to the venue in any such court; and (b) any claim that any action or proceeding brought in any such court has been brought in an inconvenient forum. 

The Maker and Lender intend and believe that each provision in this Note comports with all applicable local, state and federal laws and
judicial decisions. However, if any provision or provisions, or if any portion of any provision or provisions, in this Note is found by a court of law to be in violation of any applicable local, state or federal ordinance, statute, law,
administrative or judicial decision, or public policy, and if such court should declare such portion, provision or provisions of this Note to be illegal, invalid, unlawful, void or unenforceable as written, then it is the intent of all parties
hereto that such portion, provision or provisions shall be given force to the fullest possible extent that they are legal, valid and enforceable, that the remainder of this Note shall be construed as if such illegal, invalid, unlawful, void or
unenforceable portion, provision or provisions were not contained therein, and that the rights, obligations and interests of Maker and Lender under the remainder of this Note shall continue in full force and effect. 

It is the intention of the Maker and Lender to comply strictly with all applicable usury laws; accordingly, it is agreed that
notwithstanding any provisions to the contrary in this Note or otherwise relating hereto, in no event shall this Note or other documents require the payment or permit the collection of an aggregate amount of interest in excess of the maximum amount
permitted by any laws which may apply to this transaction, including the laws of the State of Oklahoma. 
  

  
 2 

 The terms of this Note shall be binding upon Maker and its successors and assigns and shall
inure to the benefit of Lender and his heirs, personal representatives and assigns. 
 Notwithstanding any provision of this
Note, all rights and remedies of Lender hereunder shall be fully subordinate to the Arvest Loan Documents. In the event the Arvest Loan Documents prohibit the repayment of this Note on the Maturity Date, then the Maturity Date of this Note shall be
extended day to day with interest at the rate set forth herein until the earlier of such date as the obligations of Maker under the Arvest Loan Documents have been refinanced or the provisions of the Arvest Loan Documents permit such repayment to
Lender. 
 As further consideration for Lender to make the loan evidenced by this Note and which is material to Lender in
agreeing to make such loan, Borrower does hereby irrevocably and unconditionally waive, release and forever discharge the Lender and its affiliates and each of their heirs, successors, assigns and personal representatives, and agrees to indemnify
each of them including attorney fees and costs, of and from any and all actions, causes of action, suits, damages, claims, demands or offsets of any kind or character whatsoever that the Borrower, ever had, now has, shall or may have for, upon or by
reason of any matter, cause, act, omission, or thing arising or accruing at any time from the beginning of the world through the date of this Note. 
 IN WITNESS WHEREOF, the undersigned Maker has executed this instrument effective as of August 31, 2012. 

 

			
	Graymark Healthcare, Inc., an Oklahoma Corporation
		
	By	 	/s/ Stanton M. Nelson
		 	Stanton M. Nelson, CEO

  

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00207-of-00352.parquet"}]]